- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03064958
The Acute Effect of Spices on Vascular Health
The Postprandial Effects of a High Fat Meal Containing Spices on Endothelial Function: a Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A 3-period randomized controlled crossover study will be conducted to investigate the postprandial effects of a high fat meal with spices on endothelial function, lipids/lipoproteins, immune function, plasma antioxidants and markers of oxidative stress. Metabolomic profiling will also be conducted. In random order participants will consume either a high fat meal (1000kcal, 45g fat) or a high fat meal containing 2g of spices or a high fat meal containing 6g of spices with a 3 day washout period between each treatment. The following spices will be incorporated into the meal black pepper, basil, bay leaf, cinnamon, coriander, cumin, ginger, oregano, parsley, rosemary, red pepper, turmeric and thyme.
Endothelial function will be measured by flow mediated dilation of the brachial artery in the fasting state and 2 and 4 hours after the meal. Participants will also provide a fasting blood sample and samples will also be taken at 1, 2, 3 and 4 hours after the meal.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Penn State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- male aged 40-65 years
- BMI 25-35kg/m2
- nonsmoking
- waist circumference =/> 94cm and at least one other CVD risk factor (elevated LDL-C (> 130 mg/dL), CRP (> 1 mg/L), elevated Triglycerides (≥ 150 mg/dL), reduced HDL-cholesterol (< 40 mg/dL), elevated blood pressure (systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg), elevated fasting glucose (≥ 100 mg/dL))
- low herb/spice consumers (consumption <1/day)
Exclusion Criteria:
- Chronic disease risk factors that are diagnostic of diabetes (fasting glucose > 126 mg/dL) or hypertension (SBP >160 mm Hg or DBP > 100 mm Hg).
- Prescription of anti-hypertensive or glucose lowering drugs.
- Established CVD, stroke, diabetes, liver, kidney or autoimmune disease
- Use of cholesterol/lipid-lowering medication or supplements (psyllium, fish oil, soy lecithin, and phytoestrogens) and botanicals
- weight loss of ≥10% of body weight within the 6 months prior to enrolling in the study
- vegetarianism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Consumption of a high fat meal (1000kcal, 45g fat)
|
Meal containing 1000kcal and 45g fat
|
Experimental: Spice 2g
Consumption of a high fat meal (1000kcal, 45g fat) with 2g of spice (mix of black pepper, basil, bay leaf, cinnamon, coriander, cumin, ginger, oregano, parsley, rosemary, red pepper, turmeric and thyme) incorporated into the meal.
|
Meal containing 1000kcal and 45g fat
Mix of commonly used herbs and spices
|
Experimental: Spice 6g
Consumption of a high fat meal (1000kcal, 45g fat) with 6g of spice (mix of black pepper, basil, bay leaf, cinnamon, coriander, cumin, ginger, oregano, parsley, rosemary, red pepper, turmeric and thyme) incorporated into the meal.
|
Meal containing 1000kcal and 45g fat
Mix of commonly used herbs and spices
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in endothelial function measured by flow mediated dilation (FMD) of the brachial artery
Time Frame: Change from baseline at 2 hours and 4 hours after meal consumption
|
Change from baseline at 2 hours and 4 hours after meal consumption
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Lipids and lipoproteins
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Plasma Inflammatory cytokines
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Inflammatory cytokines in isolated peripheral blood mononuclear cells
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Glucose
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Insulin
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Plasma antioxidants (hydrophilic ORAC, lipophilic ORAC, total ORAC)
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Oxidative stress
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Plasma nitrite and nitrate
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Plasma and Urine Metabolomic profiling
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Change from baseline during the 4 hours after meal consumption
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PKE SPICE PILOT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oxidative Stress
-
University of SouthamptonEuropean Space AgencyActive, not recruiting
-
University of ThessalyActive, not recruiting
-
NestléCompleted
-
University of BirminghamCompleted
-
University of KentuckyAlltech Life Sciences Inc.Completed
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeUnknown
-
Antalya Training and Research HospitalCompleted
-
Gazi UniversityCompleted
-
Chinese University of Hong KongCompleted
-
Seoul St. Mary's HospitalRural Development Administration, KoreaCompletedOxidative StressKorea, Republic of
Clinical Trials on High fat meal
-
USDA, Western Human Nutrition Research CenterTerminatedObesity | Overweight | Body WeightUnited States
-
Agroscope Liebefeld-Posieux Research Station ALPCompletedObesity | Nutritional InterventionSwitzerland
-
Pennington Biomedical Research CenterCompletedDiabetes Mellitus, Type 2United States
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Universidad IcesiUniversidad de San BuenaventuraCompletedCardiovascular DiseasesColombia
-
Wageningen UniversityTop Institute Food and NutritionCompletedCardiovascular Disease | Endothelial DysfunctionNetherlands
-
University of ReadingUnilever R&DCompletedCardiovascular DiseaseUnited Kingdom
-
Boehringer IngelheimCompleted
-
University of Missouri-ColumbiaCompleted
-
Virginia Commonwealth UniversitySigma XiCompletedLipemia | Cardiovascular Risk FactorUnited States